Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
暂无分享，去创建一个
A. Faisal | M. Valenti | A. K. de Haven Brandon | F. Raynaud | S. Eccles | P. Innocenti | A. Hayes | G. Box | J. Blagg | S. Hoelder | H. Woodward | I. Westwood | S. Anderhub | S. Linardopoulos | C. Xavier | G. Mak | Mark D. Gurden | Sébastien Naud | Lisa O’Fee | Jessica Schmitt | R. Burke | Rob vanMontfort | Mark D. J. Gurden | Rob L M vanMontfort | Simon J. Anderhub